Mikiko Kamijo

4.1k total citations
31 papers, 1.4k citations indexed

About

Mikiko Kamijo is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Mikiko Kamijo has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 13 papers in Cellular and Molecular Neuroscience and 13 papers in Neurology. Recurrent topics in Mikiko Kamijo's work include Pain Mechanisms and Treatments (10 papers), Aldose Reductase and Taurine (10 papers) and Peripheral Neuropathies and Disorders (8 papers). Mikiko Kamijo is often cited by papers focused on Pain Mechanisms and Treatments (10 papers), Aldose Reductase and Taurine (10 papers) and Peripheral Neuropathies and Disorders (8 papers). Mikiko Kamijo collaborates with scholars based in Japan and United States. Mikiko Kamijo's co-authors include Soroku Yagihashi, Anders A. F. Sima, S. A. Lattimer, D. A. Greene, Masayuki Baba, Paul Cherian, Yasuo Ido, Kazunori Nagai, Norito Yagihashi and Donald J. Mirrlees and has published in prestigious journals such as Journal of Clinical Investigation, Neurology and Diabetes.

In The Last Decade

Mikiko Kamijo

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikiko Kamijo Japan 18 695 538 503 243 219 31 1.4k
K. C. Dines United Kingdom 20 828 1.2× 261 0.5× 162 0.3× 171 0.7× 187 0.9× 32 1.4k
Martin J. Stevens United States 18 624 0.9× 267 0.5× 125 0.2× 236 1.0× 345 1.6× 23 1.8k
Yūichi Murakawa United States 15 679 1.0× 219 0.4× 313 0.6× 69 0.3× 357 1.6× 20 1.2k
Omorodola I. Abatan United States 11 472 0.7× 163 0.3× 98 0.2× 185 0.8× 206 0.9× 13 1.0k
Shin‐Ichiro Yamagishi Japan 14 344 0.5× 168 0.3× 93 0.2× 198 0.8× 170 0.8× 22 725
Jill S. Gellett United States 11 528 0.8× 125 0.2× 134 0.3× 73 0.3× 143 0.7× 11 887
S. Robertson United Kingdom 17 538 0.8× 165 0.3× 111 0.2× 147 0.6× 147 0.7× 18 829
Judyta K. Juranek Poland 17 306 0.4× 269 0.5× 128 0.3× 59 0.2× 321 1.5× 43 1.1k
E. K. Maxfield United Kingdom 9 504 0.7× 157 0.3× 77 0.2× 113 0.5× 71 0.3× 9 719
Michel Ferrand-Drake United States 13 187 0.3× 170 0.3× 336 0.7× 305 1.3× 948 4.3× 13 1.5k

Countries citing papers authored by Mikiko Kamijo

Since Specialization
Citations

This map shows the geographic impact of Mikiko Kamijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikiko Kamijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikiko Kamijo more than expected).

Fields of papers citing papers by Mikiko Kamijo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikiko Kamijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikiko Kamijo. The network helps show where Mikiko Kamijo may publish in the future.

Co-authorship network of co-authors of Mikiko Kamijo

This figure shows the co-authorship network connecting the top 25 collaborators of Mikiko Kamijo. A scholar is included among the top collaborators of Mikiko Kamijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikiko Kamijo. Mikiko Kamijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riku, Yuichi, Mari Yoshida, Takuya Tamura, et al.. (2021). Unexpected postmortem diagnoses in cases of clinically diagnosed amyotrophic lateral sclerosis. Neuropathology. 41(6). 457–467. 3 indexed citations
2.
Kuwabara, Satoshi, Masahiro Mori, Sonoko Misawa, et al.. (2017). Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial. Journal of Neurology Neurosurgery & Psychiatry. 88(10). 832–838. 41 indexed citations
3.
4.
5.
6.
Nishimoto, Yukihiro, Michiaki Koga, Mikiko Kamijo, Koichi Hirata, & Nobuhiro Yuki. (2004). Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration. Neurology. 62(11). 1939–1944. 20 indexed citations
7.
Mori, Kōichi, et al.. (2001). Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats. Diabetes Research and Clinical Practice. 51(1). 9–20. 23 indexed citations
8.
Kihara, Mikihiro, et al.. (2001). A small dose of the immunosuppressive agent FK506 (tacrolimus) protects peripheral nerve from ischemic fiber degeneration. Muscle & Nerve. 24(12). 1601–1606. 13 indexed citations
9.
Takagi, Yuji, Mikiko Kamijo, Shinji Makino, & Muneo Matsunaga. (2000). Decreased Interleukin-6 (IL-6) Synthesis in Sciatic Nerve Axotomy on Streptozotocin-Induced Diabetic Rats. 43(8). 649–655. 2 indexed citations
10.
Kamijo, Mikiko, et al.. (1996). Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: The effect of ARI treatment. Journal of Diabetes and its Complications. 10(4). 183–191. 36 indexed citations
11.
Sima, Anders A. F., Helen Ristic, Alan Merry, et al.. (1996). Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.. Journal of Clinical Investigation. 97(8). 1900–1907. 78 indexed citations
12.
Cherian, Paul, Mikiko Kamijo, Kimon J. Angelides, & Anders A. F. Sima. (1996). Nodal Na+-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: Prevention by aldose reductase inhibition. Journal of Diabetes and its Complications. 10(4). 192–200. 53 indexed citations
13.
Stevens, Martin, J. Dananberg, Eva L. Feldman, et al.. (1994). The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.. Journal of Clinical Investigation. 94(2). 853–859. 156 indexed citations
14.
Kamijo, Mikiko, Michael Basso, Paul Cherian, Thomas C. Hohman, & Anders A. F. Sima. (1994). Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy. Diabetes Research and Clinical Practice. 25(2). 117–129. 16 indexed citations
15.
Yorek, Mark A., Eric P. Davidson, Joyce A. Dunlap, et al.. (1993). Reduced Motor Nerve Conduction Velocity and Na+-K+-ATPase Activity in Rats Maintained on L-Fucose Diet: Reversal by myo-Inositol Supplementation. Diabetes. 42(10). 1401–1406. 44 indexed citations
16.
Kamijo, Mikiko, Paul Cherian, & A. A. F. Sima. (1993). The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat. Diabetologia. 36(10). 893–898. 34 indexed citations
17.
Stevens, Martin J., S. A. Lattimer, Mikiko Kamijo, et al.. (1993). Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia. 36(7). 608–614. 128 indexed citations
18.
Yagihashi, Soroku, Mikiko Kamijo, Masayuki Baba, Norito Yagihashi, & Kazunori Nagai. (1992). Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Nerve of STZ-Induced Diabetic Rats. Diabetes. 41(1). 47–52. 147 indexed citations
19.
Kamijo, Mikiko & Soroku Yagihashi. (1991). 5. Supplementary Polyol Pathway and Diabetic Neuropathy: Selective Preventive Effects of an Aldose Reductase Inhibitor in Experimental Diabetic Neuropathy. Japanese Journal of Medicine. 30(6). 629–630. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. C. Dines Breakdown of academic impact, for papers by Martin J. Stevens Breakdown of academic impact, for papers by Yūichi Murakawa Breakdown of academic impact, for papers by Omorodola I. Abatan Breakdown of academic impact, for papers by Shin‐Ichiro Yamagishi Breakdown of academic impact, for papers by Jill S. Gellett Breakdown of academic impact, for papers by S. Robertson Breakdown of academic impact, for papers by Judyta K. Juranek Breakdown of academic impact, for papers by E. K. Maxfield Breakdown of academic impact, for papers by Michel Ferrand-Drake
Rankless by CCL
2026